Baidu
map
APPL ENVIRON MICROB 润色咨询

APPLIED AND ENVIRONMENTAL MICROBIOLOGY

出版年份:1976 年文章数:23990 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:5.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2022-03-13 ms6000002020653746

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2022-09-23 ms5000000795896919

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制
    经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。
    Manuscript Accepted 2022-09-15 15:00:31
    Under Review 2022-09-15 14:08:49
    Reviewing Editor Assigned 2022-09-13 16:50:11
    Initial QC 2022-09-13 04:47:39
    Manuscript Submission Incomplete 2022-09-11 03:41:02
    大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。
    Manuscript Rejected 2022-09-05 23:26:52
    Under Review 2022-08-17 08:29:04
    Reviewing Editor Assigned 2022-08-15 15:17:09
    Initial QC 2022-08-15 01:46:08
    Manuscript Submission Incomplete 2022-08-15 00:12:41
    两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。
    Manuscript Rejected 2022-07-22 04:42:31
    Under Review 2022-06-27 12:49:53
    Reviewing Editor Assigned 2022-06-27 12:49:53
    Initial QC 2022-06-21 10:25:55
    Manuscript Submission Incomplete 2022-06-20 23:13:29

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2022-02-23 969037536

    先多向前辈了解资源,然后找老师仔细检查

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2022-02-06 ms6000002020653746

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:微生物方法
    经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2021-12-28 学医的彭于晏

    期刊可以有几个通讯作者/第一作者?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2021-12-27 衣谷

    什么是correspondingauthor/通讯作者?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2020-05-15 ms7652325115774130

    审稿速度:2.0
    经验分享:2020.3.23 投稿
    2020.3.23 送审
    2020.5.5 返回审稿意见
    2020.5.15 修回
    2020.5.15 接收

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2019-05-23 ms622773450447966

    实时if=3.2了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2019-02-19 ms7296194897309127

    1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。
    2018.9.17 submission
    2018.9.18 under review
    2018.10.28 rejected但编辑鼓励重投
    2019.1.17 submission
    2019.1.17 under review
    2019.1.30 accept
    2019.2.13 proof
    非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1202331, encodeId=d4a812023314e, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:感谢editor—Haruyuki Atomi,周日晚上8点半还在辛勤得工作!我在周日晚上8点半收到了文章接收的邮件!激动的心,颤抖的手!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Mar 13 21:48:02 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089984, encodeId=7dbb20899844e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:比较基因组方向;微生物分子生物学;酶学机制<br>经验分享:第三次修回,重新提交,很快接受。这次编辑直接拍板的。总的来说,编辑很nice,会根据文章质量和审稿人意见综合评价。<br>Manuscript Accepted 2022-09-15 15:00:31<br>Under Review 2022-09-15 14:08:49<br>Reviewing Editor Assigned 2022-09-13 16:50:11<br>Initial QC 2022-09-13 04:47:39<br>Manuscript Submission Incomplete 2022-09-11 03:41:02<br>大修那个审稿人修回后没有意见,表示接受,第二个审稿人还是给提了很多问题,有一些问题就是找事的,我们结合文献和实验数据,反驳审稿人二的意见,编辑也看出审稿人在找事。第二次被拒,中途动摇过转投,反复根据reviewer意见仔细修改,第三次重新提交。<br>Manuscript Rejected 2022-09-05 23:26:52<br>Under Review 2022-08-17 08:29:04<br>Reviewing Editor Assigned 2022-08-15 15:17:09<br>Initial QC 2022-08-15 01:46:08<br>Manuscript Submission Incomplete 2022-08-15 00:12:41<br>两个审稿人一个大修,一个拒稿,编辑建议重投,修改一个月后重新提交。<br>Manuscript Rejected 2022-07-22 04:42:31<br>Under Review 2022-06-27 12:49:53<br>Reviewing Editor Assigned 2022-06-27 12:49:53<br>Initial QC 2022-06-21 10:25:55<br>Manuscript Submission Incomplete 2022-06-20 23:13:29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=791, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=771a5714811, createdName=ms5000000795896919, createdTime=Fri Sep 23 17:28:49 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196527, encodeId=2d8d119652e1c, content=先多向前辈了解资源,然后找老师仔细检查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cedb4711784, createdName=969037536, createdTime=Wed Feb 23 20:20:48 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190531, encodeId=3232119053102, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:微生物方法<br>经验分享:两位reviewer非常负责,提的建议非常细致,同时还细心得为我提出修改语句的意见。第一次投稿遇到这么nice的reviewer,在这里感谢AEM这家杂志,谢谢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32a05571110, createdName=ms6000002020653746, createdTime=Sun Feb 06 16:20:40 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086966, encodeId=985d1086966c6, content=期刊可以有几个通讯作者/第一作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086965, encodeId=993c10869655f, content=什么是correspondingauthor/通讯作者?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860589, encodeId=201786058909, content=审稿速度:2.0<br>经验分享:2020.3.23 投稿<br> 2020.3.23 送审<br> 2020.5.5 返回审稿意见<br> 2020.5.15 修回<br> 2020.5.15 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72655414082, createdName=ms7652325115774130, createdTime=Fri May 15 15:13:03 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851551, encodeId=656c8515518d, content=实时if=3.2了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Thu May 23 20:38:35 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849766, encodeId=185c849e6627, content=1投sbb,2投em都被秒拒,3投aem,进入审稿,一开始满怀希望,但过程极其坎坷:一审2位审稿人意见中肯,1位审稿人批的一无是处,但编辑鼓励重投;大修2个半月,response和arguement合起来将近写了30页;重投后重新找了2位审稿人,加上之前1位审稿人,之前审稿人再审后表示接收,新审稿人中的1位审稿人第一句话说response写的不错,也表示接收,另一位新的审稿人说文章没有创新,给拒稿;但编辑这次给了修改,又写了将近15页的response,终于被接收。以下是审稿过程,希望对大家有用。<br> 2018.9.17 submission<br> 2018.9.18 under review <br> 2018.10.28 rejected但编辑鼓励重投<br> 2019.1.17 submission<br> 2019.1.17 under review<br> 2019.1.30 accept<br> 2019.2.13 proof<br> 非常感谢编prof. hideaki nojiri,辑期刊也不错,对文章创新性和语言要求高,希望以后还能再中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Tue Feb 19 13:50:42 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846868, encodeId=f60584686869, content=applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Sat Sep 01 12:28:23 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 ms3000046594999774

    applied and environmental microbiology是不错的期刊,课题组投过几篇都中了,但坦白的讲,跟environmental microbiology相比还是差距很大。

    0

共80条页码: 1/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map